SeaCrest Wealth Management »

Acasti Pharma shares owned by SeaCrest Wealth Management

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by SeaCrest Wealth Management from 13F filings

Historical chart of SeaCrest Wealth Management investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by SeaCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by SeaCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $42k 14k 3.00

More positions owned by SeaCrest Wealth Management

Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Amazon (AMZN)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Visa Com Cl A (V)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for SeaCrest Wealth Management

Top funds holding Acasti Pharma

Nantahala Capital Management
AIGH Capital Management
Vanguard Group
ADAR1 Capital Management
Stonepine Capital Management
Renaissance Technologies
Citadel Advisors
Millington Financial Advisors
SeaCrest Wealth Management
National Bank Of Canada /fi/
Morgan Stanley
Tower Research Capital
Royal Bank of Canada
Activest Wealth Management
SBI Securities

View all funds holding Acasti Pharma